Pain management drugs market contributed for $58.57 billion in 2016 and is expected to reach $77.13 billion by 2023, growing at a CAGR of 4% from 2017 to 2023. North America contributed the highest share in 2016, however, Asia-Pacific is estimated to grow at the highest rate during the forecast period.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/404
The ease in accessibility of advanced treatments and progress in technology have raised the life expectancy rates across the world, which in turn, resulted in surge in the geriatric population. As the geriatric population is highly prone undergo pain for various reasons, rise in their population become the crucial factor in contributing the growth in the global pain management market. According to the statistics of the UN Population Division, the total population of people above the age of 60 years has raised from 12% in 1950 to 22% in 2011. Moreover, it is expected to reach 32% by 2050.
Moreover, surge in R&D investments and increase in pharmaceutical outsourcing are projected to drive the market growth in developing countries in regions including Asia-Pacific and LAMEA. However, presence of alternative therapies and expiration of patent of prescription drugs for treatment restrict the market growth.
The opioids segment contributed the highest growth rate in 2016, owing to high efficiency of opioids that can reduce the pain occurring in chronic conditions. The anesthetics segment is expected to witness the highest growth rate by 2023.
For More Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/404
Chronic back pain and postoperative pain contributed the largest share in 2016, owing to rise in the number of surgeries across the globe and increase in prevalence of chronic diseases that cause pain. Furthermore, the cancer pain segment is estimated to register the highest growth rate during the forecast period, owing to surge in incidence of cancer worldwide.
North America is estimated to contribute the highest revenue during the forecast period. On the other hand, Asia-Pacific is expected to contribute the highest growth rate during the forecast period. This is attributed to surge in government initiatives for improvement in the healthcare infrastructure along with supportive regulatory framework.
Key Findings of the report:
- The cancer pain segment is expected to register the highest CAGR during the forecast period.
- The opioids segment contributed the highest market share in terms of revenue, and is projected to dominate during the analysis period.
- North America held nearly half of the market share, and is expected to maintain its dominance.
- China is estimated to register a CAGR of 6% during the forecast period.
- Postoperative pain contributed the largest share in the indication segment in 2016.
The key companies analyzed in the report include Novartis AG, Abbott Laboratories, Eli Lilly & Company, Purdue Pharma L.P., Endo Health Solutions, Inc., F. Hoffmann La Roche Ltd., Pfizer, Inc., Johnson & Johnson, Merck & Co. Inc., and GlaxoSmithKline Plc.
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060